VDB-175395 · CVE-2017-17678 · GCVE-0-2017-17678

BMC Remedy Mid Tier 9.1SP3 Legacy Utility cross site scripting

CVSS Meta Temp Score CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.	Current Exploit Price (≈) Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.	CTI Interest Score Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
3.5	$0-$5k	0.00

Summaryinfo

A vulnerability has been found in BMC Remedy Mid Tier 9.1SP3 and classified as problematic. Affected by this vulnerability is an unknown functionality of the component Legacy Utility. Performing a manipulation results in cross site scripting. This vulnerability is known as CVE-2017-17678. Remote exploitation of the attack is possible. No exploit is available. The affected component should be upgraded.

Detailsinfo

A vulnerability, which was classified as problematic, was found in BMC Remedy Mid Tier 9.1SP3. This affects an unknown part of the component Legacy Utility. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity.

The weakness was published 05/20/2021. It is possible to read the advisory at seclists.org. This vulnerability is uniquely identified as CVE-2017-17678. It demands that the victim is doing some kind of user interaction. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.

Upgrading eliminates this vulnerability. The upgrade is hosted for download at docs.bmc.com.

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Productinfo

Vendor

Name

Remedy Mid Tier

Version

9.1SP3

License

commercial

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 3.5
VulDB Meta Temp Score: 3.5

VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv2info

AV	AC	Au	C	I	A
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳
💳	💳	💳	💳	💳	💳

Vector	Complexity	Authentication	Confidentiality	Integrity	Availability
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock
Unlock	Unlock	Unlock	Unlock	Unlock	Unlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

Exploitinginfo

Class: Cross site scripting
CWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-Day	Unlock	Unlock	Unlock	Unlock
Today	Unlock	Unlock	Unlock	Unlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

0-Day Time: 🔍

Upgrade: docs.bmc.com

Timelineinfo

12/13/2017 🔍
05/20/2021 +1253 days 🔍
05/20/2021 +0 days 🔍
05/22/2021 +2 days 🔍

Sourcesinfo

Advisory: seclists.org
Status: Not defined

CVE: CVE-2017-17678 (🔍)
GCVE (CVE): GCVE-0-2017-17678
GCVE (VulDB): GCVE-100-175395

Entryinfo

Created: 05/20/2021 08:28
Updated: 05/22/2021 17:55
Changes: 05/20/2021 08:28 (38), 05/22/2021 17:55 (2)
Complete: 🔍
Cache ID: 216::103